Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Postoperative Pulmonary Complications in Emergency Laparotomy
NCT06304779Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2023
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pulmonary complications (PPC) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Incidence of Postoperative Pulmonary Complications. Started Oct 2023; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT06304779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06304779.